Quince Therapeutics, Inc.

QNCXNASDAQHealthcare● Active

$1.00

$-0.01(-0.99%)

Market Cap$5568150

P/E Ratio—

52W High$45.5

52W Low$0.79

Avg Volume5.2M

Open$1.02

Beta1.40

Overview

Quince Therapeutics, Inc. (QNCX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · QNCX · as of Apr 10, 2026

Latest filing snapshot

+2+5.56%vs prior year

Quince Therapeutics, Inc. (QNCX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+5.56%

Revenue / Employee

—

Net Income / Employee

$-2.21M

Market Cap

$6M

QNCX Employee Count

2019 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-04-10	2025-12-31	38	+2	+5.56%
2025-03-24	2024-12-31	36	-32	-47.06%
2024-04-01	2023-12-31	68	+47	+223.81%
2023-03-15	2022-12-31	21	-34	-61.82%
2022-03-01	2021-12-31	55	+18	+48.65%
2021-03-01	2020-12-31	37	+14	+60.87%
2020-03-16	2019-12-31	23	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ADVM

Adverum Biotechnologies, Inc.

155$96M #2

DTIL

Precision BioSciences, Inc.

108$87M #3

ALXO

ALX Oncology Holdings Inc.

65$211M #4

CNTB

Connect Biopharma Holdings Limited

CAMP4 Therapeutics Corporation

55$87M #7

QNCX

Quince Therapeutics, Inc.YOU

38$6M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · QNCX peer comparison

About QNCX employees

QNCX Employees · Headcount

Quince Therapeutics, Inc. (QNCX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Quince Therapeutics, Inc. had 38 full-time employees globally. Full-time employees only. Global consolidated headcount.

Quince Therapeutics, Inc.'s workforce increased by 2 (5.56%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

QNCX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Quince Therapeutics, Inc. had 38 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Quince Therapeutics, Inc. employee counthow many employees does Quince Therapeutics, Inc. haveQNCX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-04-10